Biodexa Pharmaceuticals (BDRX) said Monday the US Food and Drug Administration granted fast-track designation for eRapa as a potential treatment for familial adenomatous polyposis.
Shares surged 44% as intraday trading volume catapulted to over 20.5 million from a daily average of about 139,000.
DatChat (DATS) disclosed Monday the upcoming launch of its Myseum platform, a digital content management and storage solution for families, groups, and individuals.
Shares jumped 10%, with intraday trading volume rising to nearly 860,000 compared with a daily average of more than 8.72 million.
Axsome Therapeutics (AXSM) shares surged 22% after the firm said Monday it agreed to a settlement with Teva Pharmaceuticals (TEVA) to resolve "all" patent litigation related to Auvelity.
More than 3.4 million shares traded intraday compared with a daily average of about 800,000.
Price: 5.83, Change: +1.76, Percent Change: +43.24
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。